Merit Medical Is Maintained at Outperform by Barrington Research
Merit Medical Systems Analyst Ratings
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $114
Outperform Rating for Merit Medical Systems Bolstered by Positive WAVE Trial Results and Strategic Acquisitions
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI) and Thermo Fisher (TMO)
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $125
Wells Fargo Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $109
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $109
A Quick Look at Today's Ratings for Merit Medical Systems(MMSI.US), With a Forecast Between $103 to $110
Key Takeaways From Merit Medical Systems Analyst Ratings
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $103
A Quick Look at Today's Ratings for Merit Medical Systems(MMSI.US), With a Forecast Between $103 to $125
Merit Medical Is Maintained at Neutral by B of A Securities
Merit Medical Price Target Maintained With a $105.00/Share by Needham
Merit Medical Systems (MMSI) Receives a Buy From Piper Sandler
Hold Rating on Merit Medical Systems Amid Wrapsody's Positive Impact and Market Uncertainties
Merit Medical Systems Analyst Ratings
Piper Sandler Reiterates Overweight on Merit Medical Systems, Raises Price Target to $110